Medical Products and Services Marketplace

Our goal is to bring attractive acquisition and partnership or collaboration opportunities in Medical Marketplace. We are business intermediaries specialized in niche industries and have extensive working experience in biomedical and healthcare industries.

This marketplace covers biomedical / healthcare companies as well as pharmaceutical companies.

Disclaimer: TechnologyPark.com has not independently verified any of the information in these listings and makes no warranty as to their accuracies or completeness.

icon_arrow BioMedical Opportunities
icon_arrow Pharmaceutical Opportunities
icon_arrow Pharmaceutical / Medical / Lab Real Estate

Biomedical Opportunities

Tech-9094a: Licensing Opportunity for Novel Endotoxin-Binding Compounds for Sepsis Treatment
Tech-9094b: Versatile, Economical, and Extremely Flexible, Nanoparticle System for Drug Delivery - Licensing Opportunity
Tech-9092:Advanced Bio-Marker Based Digital Pap Test Incorporating Self-sampling and Telemedicine
Tech-9002: Medical Device Company with Unique Products for Orthopedic Market
Tech-2511: A Medical Device Manufacturer with an Innovative Dry Mouth Product Looking for Acquisition/Strategic Partner
Tech-9093: Saliva-based Testing Devices Manufacturer with Patented Products and Technologies
Tech-2288: Profitable, Very Reputable Specialty Pharmaceutical Research Instrument Sales and Service Company in South Atlantic US

medical_iconTech-9092:Advanced Bio-Marker Based Digital Pap Test Incorporating Self-sampling and Telemedicine. This Company offers an enhanced, patented versions of the Pap test that creates distinct red stains of cancerous and pre-cancerous cells whereas normal cells are blue. Therefore, reading and interpreting these tests very quick and easy. This patented Bio-marker test can be simply substituted in place of the conventional test. In addition, positives can be sent to a lab via telemedicine using a smart phone. it also offers self-sampling option. This test is ideal for the developing countries including India, where 70,000 lives are lost and over 300 million women are at risk. ...more ...contact us (with listing ID)

medical_icon Tech-9002: Medical Device Company with Unique Products for Orthopedic Market. The Company has a unique series of instruments that significantly improve on current products being used by orthopedic surgeons. Company's products reduce the risks in surgery and make these devices much more affordable and accessible, particularly for outpatient surgery centers and for those in developing countries. Overall, the Company addresses a $1 billion worldwide market and is the only Company with such products in the US. The Company has commercialized its products over the last year and they have been well received. The products are FDA-approved, have a CE mark, and the company has ISO accreditation. Next generation products are in the pipeline.

The Company wants to aggressively reach the US and Global market and is seeking a larger, strategic partner which can help accelerate the growth of the company. Ideally, the partner would invest in the growth of the organization and bring access to the market through its marketing network or contacts. ...contact us (with listing ID)

medical_iconTech-2511 - A Medical Device Manufacturer with an Innovative Dry Mouth Product - Acquisition/Strategic Partnership. This is the only device of its kind to address the dry mouth problem for which US$6 billion are spent annually. Both, consumer and professional versions of the products are available and approved for sale in Europe (CE), in Australia (TGA), and professional version in USA, and China (CFDA). The company is open to licensing / strategic Partnership to outright sale. ... more ...contact us (with listing ID Tech-2511)

medical_iconTech-9093- Saliva-based Testing Devices Manufacturer with Patented Products and Technologies. This 15-year old, global company is a leading company in the emerging field of non-invasive saliva based testing. It was founded to address the need for rapid testing, sample collection, and molecular diagnostics (DNA, RNA and proteins) in the life sciences area. The company continues to meet the need for more effective screening tools utilizing non-invasive test specimens, particularly oral fluids, which may be applied to the early detection of a wide range of diseases and medical disorders. The company has important licenses to salivary technologies for Alzheimer’s disease, Parkinson’s disease and sleep disorders, allowing for the future development of rapid, non-invasive tests for these debilitating diseases / disorders.

Products include a wide range of innovative saliva / oral fluid collection devices, and breakthrough point-of-care test platform device. This device has been used for developing test for stress by measuring cortisol levels in saliva in real time. This device may be applied to the development of multiple diseases or multiple biomarkers in 20 minutes, eliminating the pain associated with a blood draw. The company’s range of collection and future diagnostic tools are covered by a portfolio of 16 issued US, EU and International patents with a further 10 or more in the application phase.

The Company has successfully received grant funding in the past from both the National Institutes of Health and the Michael J Fox Foundation, among others.

The company is looking for a strategic buyer / partner. Revenues: US $2.14 million (2016), Projected Revenues: $3.3 million (2017); $7.5 million (2018); $11.3 million (2019)

...contact us (with listing ID Tech-9093)

medical_iconTech-2288: Profitable, Very Reputable Specialty Pharmaceutical Research Instrument Sales and Service Company in South Atlantic US. This is a unique opportunity of a niche business focused on pharmaceutical research market and is now experiencing rapid growth and good profits. The business is based on Fluorescence-based research instrument that the company supplies and provides service for. The Company has been operational for past 10 years and the customers admire the Company for its passion, honesty, integrity and innovations that it has brought into the marketplace. The Company offer international client base, growing sales, and excellent growth opportunity. It has three patents on its product innovations. Gross Revenue: $1.46 million (2016 projection); EBITDA: $436K (2016 projected); inventory: about $2.2 million. ...more ...contact us (mention listing ID 2288)

Pharmaceutical Opportunities

medical_iconTech-9094a: Licensing Opportunity for Novel Endotoxin-Binding Compounds for Sepsis Treatment. Our Client, a biotech company developing molecular medicine, has developed novel therapeutic agents/compounds for the treatment of sepsis. According to one estimate, sepsis has a worldwide incidence of more than 20 million cases a year, with mortality due to septic shock reaching up to 50 percent even in industrialized countries. In USA, annual costs for treatment of Sepsis exceeds $20 billion per year. Currently there is no drug for treatment of sepsis - only care regimens to alleviate the symptoms. Our client has developed novel small peptides (11 or 12 amino acids long) created by rational design aimed at neutralizing the injurious effects of endotoxins by directly binding to them and stopping the cascade of events leading to septic shock and death. ...more ...contact us (mention listing ID 9094a)

medical_icon Tech-9094b: Versatile, Economical, and Extremely Flexible, Nanoparticle System for Drug Delivery for Licensing. The Company's nanoparticles are PEG polymer based, which have proven to be very biocompatible and inert. The nanoparticles are about 20-80 nm in size are are capable of carrying a variety of molecules. The Company's technology has been proven by its licensing agreement for agricultural applications and the Company is now looking to license this for pharma applications. What makes this Company's technology attractive is: a. Water soluble nanoparticles - easily travel in biological tissues b. Biologically inert - the Polyethylene Glycol (PEG) nanoparticle capsule is non-reactive, non-toxic and biodegradable c. Simple and "Green" technology - mild reaction conditions, recyclable biocatalysts, basic equipment d. Unparalleled versatility – offer infinite possibilities of the structure and utility of our nanoparticles, due to synthesis process and amphiphilic (hydrophilic and hydrophilic) nature of the nanospheres. ...contact us (mention listing ID 9094b)

medical_iconTech-2518:Licensing / Strategic Partnership Opportunity: Granulocyte Infusion - Intriguing Possibility of Curing Cancer. We have an exciting collaboration / licensing opportunity for potential treatment (or possibly a cure) for cancer. This invention had 100% success in studies in mice, very promising results in pre-clinical, in vitro human studies. If this can be translated in human therapy, then the treatment or cure for many cancers will be not that far off in the future. ... more ...contact us (with listing ID)

medical_iconTech 2520 - Licensing Opportunity for clinically tested herbal cream to treat dry, itchy and infected skin. This product was developed by a doctor with extensive experience in treating patients with eczema, psoriasis, and dry, itchy or infected skin. ... more ...contact us (with listing ID)

medical_iconSearching for Pharma Manufacturers: We have multiple buyers looking currently for pharma manufacturing companies in North America and Europe. Ideally, looking for revenues between $5 million plus, but they may also consider smaller companies. Buyers include pharmaceutical companies from around the world. ...contact us

Pharmaceutical / Lab / Medical Real Estate

Contact us for your real estate needs related to pharma research / manufacturing spaces and medical clinics. Although we hold real estate license in NJ, we can help you in many other states in the US through our network of real estate professionals.

We Can Help You Implement Your Strategy

Are you looking to find a suitable business or looking to find strategic partners? We can find customized solutions that will help you in implementing your strategies. Contact us today.